O

Ocugen
D

OCGN

0.77420
USD
0.01
(1.48%)
مغلق
حجم التداول
24,686
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
225,540,161
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADVM
    0.04000
    (0.89%)
    4.52000 USD
    A
    ALT
    0.12500
    (1.80%)
    7.06500 USD
    BNTX
    BNTX
    6.890
    (5.97%)
    122.220 USD
    C
    CODX
    -0.03820
    (-4.51%)
    0.80960 USD
    I
    INO
    0.04000
    (1.77%)
    2.30000 USD
    MRNA
    MRNA
    3.940
    (10.24%)
    42.430 USD
    N
    NVAX
    0.70000
    (7.91%)
    9.54500 USD
    V
    VXRT
    -0.04700
    (-5.78%)
    0.76590 USD
    المزيد
الأخبار
المقالات

العنوان: Ocugen

القطاع: Healthcare
الصناعة: Biotechnology
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").